30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Savara Inc (SVRA)

Track

Stock chart
Ticker: SVRA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
RAMSAY DAVID A
1 sale — total 121,220 USD
Sale 19 Dec 2025
Value US$4,522,922.02 | Price 183.23 | Shares 33,940
Proposed sale 18 Dec 2025
Value US$262,302.82 | Price 235.41 | Shares 50,958
Buy 20 Jun 2025
Value US$98,571.90 | Price 2.04 | Shares 48,225
Buy 29 May 2025
Value US$20,825.00 | Price 2.08 | Shares 10,000
Buy 31 Mar 2025
Value US$416,250.00 | Price 2.78 | Shares 150,000
Proposed sale 16 Dec 2024
Value US$180,800.00 | Price 3.31 | Shares 54,702
Sale 16 Dec 2024
Value US$180,828.40 | Price 3.31 | Shares 54,702
Proposed sale 16 Dec 2024
Value US$26,300.00 | Price 3.29 | Shares 8,000
Sale 16 Dec 2024
Value US$26,568.80 | Price 3.32 | Shares 8,000
Proposed sale 16 Dec 2024
Value US$82,500.00 | Price 3.30 | Shares 25,000
Sale 16 Dec 2024
Value US$83,277.50 | Price 3.33 | Shares 25,000
Buy 19 Nov 2024
Value US$59,072.00 | Price 2.95 | Shares 20,000
Buy 18 Nov 2024
Value US$287,600.00 | Price 2.88 | Shares 100,000
Sale 28 Dec 2023
Value US$395,900.40 | Price 4.71 | Shares 84,000
Proposed sale 28 Dec 2023
Value US$398,000.00 | Price 4.74 | Shares 84,000
Sale 28 Dec 2023
Value US$442,291.44 | Price 4.71 | Shares 93,843
Proposed sale 28 Dec 2023
Value US$448,569.00 | Price 4.78 | Shares 93,843
Sale 28 Dec 2023
Value US$47,131.00 | Price 4.71 | Shares 10,000
Proposed sale 28 Dec 2023
Value US$47,400.00 | Price 4.74 | Shares 10,000
Buy 17 Jul 2023
Value US$999,999.00 | Price 3.00 | Shares 333,333
Buy 17 Jul 2023
Value US$999,999.00 | Price 3.00 | Shares 333,333
Buy 17 Jul 2023
Value US$999,999.00 | Price 3.00 | Shares 333,333
Buy 17 Jul 2023
Value US$999,999.00 | Price 3.00 | Shares 333,333
Buy 17 Jul 2023
Value US$999,999.00 | Price 3.00 | Shares 333,333
Buy 17 Jul 2023
Value US$999,999.00 | Price 3.00 | Shares 333,333
Buy 17 Jul 2023
Value US$999,999.00 | Price 3.00 | Shares 333,333
Buy 17 Jul 2023
Value US$999,999.00 | Price 3.00 | Shares 333,333
Buy 17 Jul 2023
Value US$999,999.00 | Price 3.00 | Shares 333,333
Buy 17 Jul 2023
Value US$999,999.00 | Price 3.00 | Shares 333,333
Buy 26 Jun 2023
Value US$19,045.00 | Price 2.93 | Shares 6,500
Buy 26 May 2023
Value US$97,599.00 | Price 2.63 | Shares 37,124
Buy 25 May 2023
Value US$33,129.95 | Price 2.57 | Shares 12,876
Buy 24 May 2023
Value US$127,800.00 | Price 2.56 | Shares 50,000
Buy 30 Dec 2022
Value US$44,834.00 | Price 1.55 | Shares 29,000
Buy 29 Dec 2022
Value US$10,752.00 | Price 1.54 | Shares 7,000
Buy 28 Dec 2022
Value US$4,923.04 | Price 1.50 | Shares 3,293
Buy 23 Dec 2022
Value US$22,665.20 | Price 1.44 | Shares 15,707
Buy 22 Dec 2022
Value US$61,127.06 | Price 1.48 | Shares 41,414
Buy 22 Dec 2022
Value US$5,401.90 | Price 1.54 | Shares 3,500
Buy 20 Dec 2022
Value US$5,307.28 | Price 1.48 | Shares 3,586
Buy 20 Dec 2022
Value US$20,758.83 | Price 1.50 | Shares 13,830
Buy 19 Dec 2022
Value US$60,834.19 | Price 1.49 | Shares 40,719
Buy 16 Dec 2022
Value US$511.50 | Price 1.50 | Shares 341
Buy 23 Nov 2022
Value US$6,633.79 | Price 1.44 | Shares 4,610
Buy 22 Nov 2022
Value US$22,018.40 | Price 1.42 | Shares 15,495
Buy 21 Nov 2022
Value US$35,532.10 | Price 1.42 | Shares 25,005
Buy 18 Nov 2022
Value US$21,606.20 | Price 1.34 | Shares 16,100
Buy 17 Nov 2022
Value US$11,303.00 | Price 1.27 | Shares 8,900
Buy 27 Sep 2022
Value US$101,381.20 | Price 1.37 | Shares 73,893
Buy 26 Sep 2022
Value US$43,052.09 | Price 1.38 | Shares 31,107
Buy 23 Sep 2022
Value US$42,660.00 | Price 1.42 | Shares 30,000
Buy 20 Sep 2022
Value US$870.00 | Price 1.45 | Shares 600
Buy 19 Sep 2022
Value US$2,039.80 | Price 1.46 | Shares 1,400
Buy 16 Sep 2022
Value US$8,652.00 | Price 1.44 | Shares 6,000
Buy 8 Sep 2022
Value US$40,571.00 | Price 1.40 | Shares 29,000
Buy 7 Sep 2022
Value US$2,950.05 | Price 1.39 | Shares 2,130
Buy 6 Sep 2022
Value US$1,200.60 | Price 1.38 | Shares 870
Buy 1 Sep 2022
Value US$56,470.56 | Price 1.42 | Shares 39,768
Buy 31 Aug 2022
Value US$56,199.96 | Price 1.42 | Shares 39,494
Buy 30 Aug 2022
Value US$29,261.32 | Price 1.41 | Shares 20,738
Buy 22 Jun 2022
Value US$56,355.00 | Price 1.45 | Shares 39,000
Buy 21 Jun 2022
Value US$29,109.72 | Price 1.38 | Shares 21,094
Buy 17 Jun 2022
Value US$52,915.36 | Price 1.33 | Shares 39,906
Buy 17 Dec 2021
Value US$4,568.80 | Price 1.14 | Shares 4,000
Buy 17 Dec 2021
Value US$28,225.00 | Price 1.13 | Shares 25,000
Buy 15 Dec 2021
Value US$16,260.00 | Price 1.08 | Shares 15,000
Buy 10 Dec 2021
Value US$36,365.00 | Price 1.04 | Shares 35,000
Buy 9 Dec 2021
Value US$26,250.00 | Price 1.05 | Shares 25,000
Buy 8 Dec 2021
Value US$13,814.85 | Price 1.05 | Shares 13,157
Buy 8 Dec 2021
Value US$6,889.35 | Price 1.06 | Shares 6,500
Buy 7 Dec 2021
Value US$12,399.62 | Price 1.05 | Shares 11,843
Buy 2 Dec 2021
Value US$10,954.00 | Price 1.10 | Shares 10,000
Buy 2 Dec 2021
Value US$23,233.88 | Price 1.09 | Shares 21,394
Buy 1 Dec 2021
Value US$3,894.48 | Price 1.08 | Shares 3,606
Buy 1 Dec 2021
Value US$9,765.00 | Price 1.09 | Shares 9,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-19 2025-12-19 S Sale
3.5
RAMSAY DAVID A
Non-Executive Director
33,940 +41.2%
183.23
US$4,522,922 		33,940 +41.2% 183.23 US$4,522,922
2025-12-18 2025-12-18 PrS Proposed sale
3.5
RAMSAY DAVID A

Director

Non-Executive Director
50,958
235.41
US$262,303 		50,958 235.41 US$262,303
2025-06-23 2025-06-20 B Purchase
4.2
Hawkins Richard J
Non-Executive Director
54,910 -29.0%
94.11
US$2,156,085 		54,910 -29.0% 94.11 US$2,156,085
2025-06-02 2025-05-29 B Purchase
2.6
McCracken Joseph S
Non-Executive Director
10,000 +4.0%
2.08
US$20,825 		10,000 +4.0% 2.08 US$20,825
2025-04-01 2025-03-31 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
150,000 +6.3%
2.78
US$416,250 		150,000 +6.3% 2.78 US$416,250
2024-12-16 2024-12-16 PrS Proposed sale
2.8
Pauls Matthew

Director

Non-Executive Director
54,702
3.31
US$180,800 		54,702 3.31 US$180,800
2024-12-16 2024-12-16 PrS Proposed sale
4.2
Hawkins Richard J

Director

Non-Executive Director
8,000
3.29
US$26,300 		8,000 3.29 US$26,300
2024-12-16 2024-12-16 PrS Proposed sale
3.2
Lowrance David L

Officer

Officer
25,000
3.30
US$82,500 		25,000 3.30 US$82,500
2024-12-16 2024-12-16 S Sale
3.2
Lowrance David L

Chief Financial Officer

Officer
25,000 -6.2%
3.33
US$83,278 		25,000 -6.2% 3.33 US$83,278
2024-12-16 2024-12-16 S Sale
4.2
Hawkins Richard J
Non-Executive Director
8,000 -10.6%
3.32
US$26,569 		8,000 -10.6% 3.32 US$26,569
2024-12-16 2024-12-16 S Sale
2.8
Pauls Matthew

CHIEF EXECUTIVE OFFICER

Executive Director
54,702 -3.4%
3.31
US$180,828 		54,702 -3.4% 3.31 US$180,828
2024-11-20 2024-11-19 B Purchase
2.6
McCracken Joseph S
Non-Executive Director
20,000 +10.5%
2.95
US$59,072 		20,000 +10.5% 2.95 US$59,072
2024-11-18 2024-11-18 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
100,000 +4.5%
2.88
US$287,600 		100,000 +4.5% 2.88 US$287,600
2023-12-29 2023-12-28 S Sale
2.8
Pauls Matthew

CHIEF EXECUTIVE OFFICER

Executive Director
84,000 -6.1%
4.71
US$395,900 		84,000 -6.1% 4.71 US$395,900
2023-12-29 2023-12-28 S Sale
3.3
Elam Nevan C
Non-Executive Director
93,843 -80.7%
4.71
US$442,291 		93,843 -80.7% 4.71 US$442,291
2023-12-29 2023-12-28 S Sale
3.2
Lowrance David L

CHIEF FINANCIAL OFFICER

Officer
10,000 -2.8%
4.71
US$47,131 		10,000 -2.8% 4.71 US$47,131
2023-12-28 2023-12-28 PrS Proposed sale
2.8
Pauls Matthew

Officer; Director

Executive Director
84,000
4.74
US$398,000 		84,000 4.74 US$398,000
2023-12-28 2023-12-28 PrS Proposed sale
3.2
Lowrance David L

Officer

Officer
10,000
4.74
US$47,400 		10,000 4.74 US$47,400
2023-12-28 2023-12-28 PrS Proposed sale
3.3
Elam Nevan C

Director

Non-Executive Director
93,843
4.78
US$448,569 		93,843 4.78 US$448,569
2023-07-19 2023-07-17 B Purchase
2.5
BASKETT FOREST
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
2.6
Florence Anthony A. Jr.
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
1.5
Behbahani Ali
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.1
Yang Rick
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.5
Chang Carmen
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.9
Walker Paul Edward
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.1
Mathers Edward T
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.2
Growth Equity Opportunities 17, LLC
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
2.7
Makhzoumi Mohamad
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-06-27 2023-06-26 B Purchase
3.6
Pratt Raymond Dennis

Chief Medical Officer

Officer
6,500 +4.2%
2.93
US$19,045 		6,500 +4.2% 2.93 US$19,045
2023-05-26 2023-05-26 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
37,124 +1.7%
2.63
US$97,599 		37,124 +1.7% 2.63 US$97,599
2023-05-26 2023-05-25 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
12,876 +0.6%
2.57
US$33,130 		12,876 +0.6% 2.57 US$33,130
2023-05-26 2023-05-24 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
50,000 +2.4%
2.56
US$127,800 		50,000 +2.4% 2.56 US$127,800
2023-01-03 2022-12-30 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
29,000 +1.4%
1.55
US$44,834 		29,000 +1.4% 1.55 US$44,834
2023-01-03 2022-12-29 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
7,000 +0.3%
1.54
US$10,752 		7,000 +0.3% 1.54 US$10,752
2022-12-28 2022-12-28 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
3,293 +0.2%
1.50
US$4,923 		3,293 +0.2% 1.50 US$4,923
2022-12-28 2022-12-23 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
15,707 +0.8%
1.44
US$22,665 		15,707 +0.8% 1.44 US$22,665
2022-12-22 2022-12-22 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
41,414 +2.1%
1.48
US$61,127 		41,414 +2.1% 1.48 US$61,127
2022-12-22 2022-12-22 B Purchase
3.6
Pratt Raymond Dennis

Chief Medical Officer

Officer
3,500 +2.3%
1.54
US$5,402 		3,500 +2.3% 1.54 US$5,402
2022-12-22 2022-12-20 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
3,586 +0.2%
1.48
US$5,307 		3,586 +0.2% 1.48 US$5,307
2022-12-20 2022-12-20 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
13,830 +0.7%
1.50
US$20,759 		13,830 +0.7% 1.50 US$20,759
2022-12-20 2022-12-19 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
40,719 +2.1%
1.49
US$60,834 		40,719 +2.1% 1.49 US$60,834
2022-12-20 2022-12-16 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
341 +0.0%
1.50
US$512 		341 +0.0% 1.50 US$512
2022-11-25 2022-11-23 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
4,610 +0.2%
1.44
US$6,634 		4,610 +0.2% 1.44 US$6,634
2022-11-25 2022-11-22 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
15,495 +0.8%
1.42
US$22,018 		15,495 +0.8% 1.42 US$22,018
2022-11-21 2022-11-21 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
25,005 +1.3%
1.42
US$35,532 		25,005 +1.3% 1.42 US$35,532
2022-11-21 2022-11-18 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
16,100 +0.9%
1.34
US$21,606 		16,100 +0.9% 1.34 US$21,606
2022-11-21 2022-11-17 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
8,900 +0.5%
1.27
US$11,303 		8,900 +0.5% 1.27 US$11,303
2022-09-27 2022-09-27 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
73,893 +4.1%
1.37
US$101,381 		73,893 +4.1% 1.37 US$101,381
2022-09-27 2022-09-26 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
31,107 +1.8%
1.38
US$43,052 		31,107 +1.8% 1.38 US$43,052
2022-09-27 2022-09-23 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
30,000 +1.7%
1.42
US$42,660 		30,000 +1.7% 1.42 US$42,660
2022-09-20 2022-09-20 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
600 +0.0%
1.45
US$870 		600 +0.0% 1.45 US$870
2022-09-20 2022-09-19 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
1,400 +0.1%
1.46
US$2,040 		1,400 +0.1% 1.46 US$2,040
2022-09-20 2022-09-16 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
6,000 +0.3%
1.44
US$8,652 		6,000 +0.3% 1.44 US$8,652
2022-09-08 2022-09-08 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
29,000 +1.7%
1.40
US$40,571 		29,000 +1.7% 1.40 US$40,571
2022-09-08 2022-09-07 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
2,130 +0.1%
1.39
US$2,950 		2,130 +0.1% 1.39 US$2,950
2022-09-08 2022-09-06 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
870 +0.1%
1.38
US$1,201 		870 +0.1% 1.38 US$1,201
2022-09-01 2022-09-01 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
39,768 +2.4%
1.42
US$56,471 		39,768 +2.4% 1.42 US$56,471
2022-09-01 2022-08-31 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
39,494 +2.4%
1.42
US$56,200 		39,494 +2.4% 1.42 US$56,200
2022-09-01 2022-08-30 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
20,738 +1.3%
1.41
US$29,261 		20,738 +1.3% 1.41 US$29,261
2022-06-22 2022-06-22 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
39,000 +2.5%
1.45
US$56,355 		39,000 +2.5% 1.45 US$56,355
2022-06-22 2022-06-21 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
21,094 +1.4%
1.38
US$29,110 		21,094 +1.4% 1.38 US$29,110
2022-06-22 2022-06-17 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
39,906 +2.7%
1.33
US$52,915 		39,906 +2.7% 1.33 US$52,915
2021-12-17 2021-12-17 B Purchase
3.2
Lowrance David L

CHIEF FINANCIAL OFFICER

Officer
4,000 +2.9%
1.14
US$4,569 		4,000 +2.9% 1.14 US$4,569
2021-12-17 2021-12-17 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
25,000 +1.8%
1.13
US$28,225 		25,000 +1.8% 1.13 US$28,225
2021-12-17 2021-12-15 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
15,000 +1.1%
1.08
US$16,260 		15,000 +1.1% 1.08 US$16,260
2021-12-13 2021-12-10 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
35,000 +2.5%
1.04
US$36,365 		35,000 +2.5% 1.04 US$36,365
2021-12-09 2021-12-09 B Purchase
3.1
Chowdhury Badrul A.

CHIEF MEDICAL OFFICER

Officer
25,000 +16.7%
1.05
US$26,250 		25,000 +16.7% 1.05 US$26,250
2021-12-09 2021-12-08 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
13,157 +1.0%
1.05
US$13,815 		13,157 +1.0% 1.05 US$13,815
2021-12-08 2021-12-08 B Purchase
2.8
Pauls Matthew

CHIEF EXECUTIVE OFFICER

Executive Director
6,500 +1.7%
1.06
US$6,889 		6,500 +1.7% 1.06 US$6,889
2021-12-09 2021-12-07 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
11,843 +0.9%
1.05
US$12,400 		11,843 +0.9% 1.05 US$12,400
2021-12-02 2021-12-02 B Purchase
2.8
Pauls Matthew

CHIEF EXECUTIVE OFFICER

Executive Director
10,000 +2.7%
1.10
US$10,954 		10,000 +2.7% 1.10 US$10,954
2021-12-02 2021-12-02 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
21,394 +1.6%
1.09
US$23,234 		21,394 +1.6% 1.09 US$23,234
2021-12-02 2021-12-01 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
3,606 +0.3%
1.08
US$3,894 		3,606 +0.3% 1.08 US$3,894
2021-12-01 2021-12-01 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
9,000 +0.7%
1.09
US$9,765 		9,000 +0.7% 1.09 US$9,765
Explore more

More insider trading research around Savara Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America